SOD1 and hypertensive disorder: In vivo, studies have shown that the inward and hypertrophic microvascular remodeling processes that are observed in animal models of hypertension are decreased by blockade of the angiotensin II type 1 receptor [128], up-regulation of SOD [76] or treatment with the SOD mimetic, tempol [62,76,129,130].